News
-
-
-
-
PRESS RELEASE
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
HBM Healthcare Investments AG shareholders approve all Board of Directors' proposals at the Shareholders’ Meeting. Details on re-elected board members, compensation, and par value repayment announced -
-
-
-
-
-
PRESS RELEASE
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
HBM Healthcare Investments announces Yellow Jersey Therapeutics acquisition by Johnson & Johnson for USD 1.25 billion. Transaction increases NAV per HBM share by CHF 8.70 (+3.5%) with expected cash inflow of USD 78 million